This study aims to assess Heart-type fatty acid-binding protein (HFABP) (cardiac biomarker), markers of glycaemic control and renal function among individuals recently diagnosed with type 2 diabetes mellitus. This evidence concerns the gene FABP3 and type 2 diabetes mellitus.